Emmaus Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2.13	1.39	2.55	2.02	2.28
Cash & Short-Term Investments	2.13	1.39	2.55	2.02	2.28
Cash Growth	53.13%	-45.47%	26.03%	-11.32%	-8.36%
Receivables	2.8	2.62	5.52	0.38	1.04
Inventory	1.56	1.64	1.71	2.38	4.39
Prepaid Expenses	1.26	0.89	1.13	1.07	0.99
Other Current Assets	-	0.23	0.6	0.45	0.39
Total Current Assets	7.75	6.77	11.51	6.29	9.09
Property, Plant & Equipment	0.88	1.58	2.4	2.87	3.63
Long-Term Investments	12.6	15.04	20.98	38.8	43.72
Other Long-Term Assets	0.21	0.22	0.3	0.26	0.3
Total Assets	21.44	23.6	35.18	48.23	56.73
Accounts Payable	22.62	0.59	0.52	0.3	0.26
Accrued Expenses	-	21.32	18.59	14.45	8.93
Short-Term Debt	3.13	10.47	11.34	9.18	3.6
Current Portion of Long-Term Debt	25.4	17.01	16.38	14.66	10.16
Current Portion of Leases	0.35	2.42	1.64	0.7	0.74
Current Unearned Revenue	-	10	10	10	-
Other Current Liabilities	17.58	1.74	3.04	5.04	13.41
Total Current Liabilities	69.07	63.56	61.51	54.32	37.1
Long-Term Debt	2.27	2.25	2.23	3.73	4.65
Long-Term Leases	1.41	0.82	1.84	2.55	3.26
Long-Term Unearned Revenue	-	-	-	-	10
Other Long-Term Liabilities	12.29	13.47	17.36	21.71	23.17
Total Liabilities	85.04	80.08	82.94	82.32	78.18
Common Stock	0.07	0.06	0.06	0.05	0.05
Additional Paid-In Capital	225.99	225.9	225.33	220.82	220.02
Retained Earnings	-270.07	-262.58	-256.12	-252.34	-241.27
Comprehensive Income & Other	-19.6	-19.86	-17.03	-2.62	-0.26
Shareholders' Equity	-63.61	-56.48	-47.76	-34.09	-21.45
Total Liabilities & Equity	21.44	23.6	35.18	48.23	56.73
Total Debt	32.56	32.96	33.42	30.82	22.41
Net Cash (Debt)	-30.43	-31.57	-30.88	-28.8	-20.13
Net Cash Per Share	-0.48	-0.50	-0.58	-0.58	-0.41
Filing Date Shares Outstanding	70.19	63.87	61.85	50.93	49.31
Total Common Shares Outstanding	70.19	63.87	61.85	49.58	49.31
Working Capital	-61.33	-56.79	-50	-48.03	-28.01
Book Value Per Share	-0.91	-0.88	-0.77	-0.69	-0.43
Tangible Book Value	-63.61	-56.48	-47.76	-34.09	-21.45
Tangible Book Value Per Share	-0.91	-0.88	-0.77	-0.69	-0.43
Machinery	-	0.39	0.48	0.47	0.45
Construction In Progress	-	-	-	-	0.06
Leasehold Improvements	-	0.02	0.04	0.04	0.04

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.